



Comparing mortality risk reduction, life expectancy gains, and 
probability of achieving the full life span, as alternatives for 
presenting   CVD mortality risk reduction: A discrete choice study 
of framing risk and health behaviour change 
Abstract 
The growing rate of obesity has recently required governments to divert considerable resources in the 
promotion of healthy lifestyles.  We explored the relative effectiveness in inducing healthy behaviour 
change of three different communication strategies about the benefits of an intervention that reduces 
the mortality risks of cardiovascular disease (CVD) and encourages respondents to embrace healthier 
lifestyles. We designed a Discrete Choice Experiments questionnaire to analyse the trade-off between 
lifestyles, defined in terms of diet and exercise, and reduction in cardiovascular disease (CVD) 
mortality risk. We set three ways of framing an identical benefit: (A) as a reduction in mortality risk 
from cardiovascular disease, (B) as an increase in months of life expectancy,  and (C) as an increase 
in the probability of reaching an individual’s full lifespan. The experiment was tailored for each subject 
in the sample according to his/her individual’s baseline information on diet and physical activity. 
During the period February 2010 - July 2011, we interviewed 1,008 individuals in Northern Ireland, 
split randomly into three samples for the three CVD risk reduction frames. Considering the models’ 
goodness of fit and significance, we conclude that the most effective way of communicating these 
CVD health benefits is using an increase in life expectancy, since with this frame individuals are more 
inclined to state that they would change to a healthier lifestyle. 
Keywords: Northern Ireland (UK), Framing CVD mortality risk reduction, Health behaviour change, 
Value of statistical life, Value of a life year, Life expectancy, Stated preferences, discrete choice 





Obesity has become a growing problem affecting most Western societies. According to the 
World Health Organization (WHO), in 2008 there were about 1.5 billion overweight adults. 
This figure is increasing due to sedentary lifestyles and worsening eating habits (WHO, 
2011). In Northern Ireland, almost 70% of adults are either overweight or obese and, 
according to the Public Health Agency, the number is growing. This epidemic has become 
an economic burden (Müller-Riemenschneider, 2007), as well as a major health problem, 
as obesity increases the risk of type 2 diabetes, cancer and cardiovascular diseases (CVD). 
As a result, governments and public health agencies are diverting considerable resources 
to prevent obesity and promote healthy lifestyles (WHO, 2001; Fit Futures, 2006; Foresight 
Report, 2007; DHSSPS, 2010).  
The effectiveness of these policies has been rarely assessed because an ex-post assessment 
requires certain conditions that are difficult to achieve (Capacci et al. 2012). Using Stated 
Preferences (SP) previous studies have done ex-ante analysis and estimate the monetary 
benefits of programmes aimed at reducing the mortality risk of cardiovascular disease 
(Tolley et al, 1994, Cameron et al, 2008, Chestnut et al, 2012, Olofsson et al, 2016).  
In this paper, we explore the relative effectiveness in inducing healthy behaviour change 
of three different communication strategies about the benefits of an intervention that 
reduces the mortality risks of cardiovascular disease (CVD) and encourages respondents  
to embrace healthier lifestyles. We compare three methods for presenting identical health 
outcomes: as a CVD mortality risk reduction (Outcome Frame A), as an increase in life 
expectancy (Outcome Frame B), as an increase in the probability of reaching an 
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individual’s full lifespan (Outcome Frame C). These three approaches also allow us to 
estimate and compare the willingness to pay (WTP) for mortality risk reduction expressed 
in terms of the value of a statistical life (VSL) (Jones-Lee, 1974; Viscusi, 1993; Viscusi 
and Aldy, 2003; Jenkins et al, 2001; Blomquist, 2004; Gayer et al., 2000, 2002; Alberini 
and Ščasný, 2011; Krupnick et al, 2002; Tsuge et al, 2005) and the value of a life year lost 
(VOLY) (Chilton et al, 2002, Desaigues et al, 2007). This will allow us to suggest policy 
recommendations use the most effective framework to induce this type of health behaviour 
change.  
The literature distinguishes between two types of interventions: those that aim for the early 
detection of disease and those that aim to change behaviours that contribute to the risk of 
disease. An early detection intervention attempts to convince people of the benefits of 
screening (i.e. breast examination for cancer) in order to mitigate and improve the 
outcomes of certain conditions. A behaviour change intervention tries to persuade 
individuals to adopt a healthier lifestyle to obtain a specific health outcome, for example, 
by attempting to persuade people to change their diet, alcohol consumption, or smoking 
habits. A loss framing message in health interventions expresses what would be the likely 
outcome in the event that the individual does not act in a certain way (i.e. lack of adequate 
exercise increases the likelihood of suffering from CVD), whereas a positive framing 
highlights the benefits of acting in a certain way (doing exercise reduces the chances of 
suffering from CVD). Framing in terms of loss or gain has an impact on an individual’s 
choices (Rothman et al. 2006; Rothman & Salovey, 1997). The consensus is that, for early 
detection behaviour, a loss-framing message is more impactful (see, for instance, Edwards 
et al 2001), which is consistent with Kahneman and Tversky’s (2013) prospect theory. By 
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contrast, a gain-framing message is more appealing for behaviour change. There is natural 
variability in results depending on the intervention and health status of the individual. For 
instance, Van Assema et al. (2001) find mixed results in nutrition interventions, whereas 
Latimer et al (2008) confirm the greater effectiveness of gain framing messages for 
physical activity. Regarding the type of individual, if people are already involved with a 
particular health issue, a loss-framing message might be more impactful (Tanner et al 2008). 
Our analysis proposes a gain-framing message: individuals are informed that if they follow 
certain lifestyles, their health will improve. However, the literature has seldom explored 
the way that this outcome is expressed within a particular gain-framing strategy. Kelly and 
Rothman (2001), mentioned in Rothman et al (2006), compared a health problem versus a 
health benefit: “when people were encouraged to test for a health problem, a loss framed 
pamphlet was more effective […] but when people were encouraged to test for a health 
benefit, a gain framed pamphlet was more effective” (Rothman et al 2006, p S210). 
Following Kelly and Rothman (2001), we test whether a gain-frame presentation of health 
benefits (outcome Frame B and C) is more valuable than a gain-frame presentation of 
reduced health risks (outcome frame A).  
Several monetary valuation studies have used the concepts of mortality risk reduction (see 
for example Krupnick et al, 2002; Alberini et al, 2004; Alberini and Ščasný, 2011), or life 
expectancy gains (Chilton et al, 2002, Desaigues et al, 2007). The concept of achieving an 
individual’s full life span has been frequently used in policymaking (Andersen, 2017), 
however no Stated Preference WTP study has compared the three frames.  
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Following Kelly and Rothman (2001), we test whether a gain-frame presentation of 
health benefits is more valuable than a gain-frame presentation of reduced health risks 
with the following ex-ante hypotheses: 
H1) WTP for VOLY delivered by Outcome Frame A < WTP for VOLY delivered by 
Outcome Frame B or C 
In addition, as many benefits in public health have traditionally been communicated as 
additional life years, and as this concept is easily grasped by the general public we seek 
to test the hypothesis that WTP for VOLY delivered by Outcome Frame B is larger than 
WTP for VOLY delivered though Outcome Frames A or Frame C: 
H2) WTP for VOLY delivered by Outcome Frame A and Frame C < WTP for VOLY 
delivered by Outcome Frame B. 
If hypothesis H2 is not rejected, than Outcome Frame B should be recommended for 
policy communication  when the goal is to obtain participants’ commitments towards a 
behaviour change and to embrace healthier lifestyles in the context of CVD risks . 
With this purpose, we analyse a complex intervention that combines diet and physical 
activity with its subsequent health effects within a Discrete Choice Model-Stated 
Preference framework. The departure point is the individual’s status quo in terms of diet, 
exercise and cardiovascular risk. This lifestyle is set after we obtain information from a 
detailed individually tailored questionnaire as outlined in Grisolía et al (2013, 2015). 
We find that the most effective way of communicating health benefits in this case is using 
an increase in life expectancy, Outcome Frame B. Our estimates for VSL and VOLY are 
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within the ranges of values obtained in the literature, which lends credence to our risk 
communication and behaviour change study. 
Section 2 describes the concepts of VSL and VOLY. Section 3 presents the questionnaire, 
the Outcome Frames A, B, and C, the experimental design and the data collection. Section 
4 presents the econometric models. Sections 5 and 6 report the results and discussions 
respectively, and section 7 concludes the paper.   
 
2. VSL vs VOLY 
 
2.1. The value of statistical life (VSL) 
The VSL can be defined as the marginal rate of substitution between wealth and mortality 
risks for the entire population (Jones-Lee, 1974; Viscusi, 1993). This trade-off can be 
studied by observing people’s actual choices of jobs or goods - revealed preferences (RP) 
- or by examining individual’s choices in stated preference (SP) surveys. In the first case 
economists analyse wage-risk in the labour market for dangerous occupations (Mrozek and 
Taylor, 2002; Viscusi and Aldy, 2003) or averting cost expenditures (see, for instance 
Blomquist, 2004). Some observers point out that RP methods could be inappropriate 
because they might not reflect the general population’s behaviour, but only the behaviour 
of certain types of individuals (e.g. industrial workers) (OECD, 2011; Baker et al, 2008). 
For this reason, it has become popular to use SP studies. Although some countries, in  
particular the US, still rely on RP methods, the EU regulatory practice is based on SP 
research, and Canada and Australia are increasingly moving towards SP for VSL 
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calculations. SP methods, however, can have high cognitive requirements and are subject 
to several potential biases. In addition, the situations are hypothetical by definition. 
Government agencies have undertaken exhaustive analyses of VSL estimates. The overall 
mean of a selected number of high quality SP studies in OECD countries shows, VSL 
estimates ranges from USD 1.45 to 4.35 million (2005-USD), with an average of USD 2.9 
million (Lindhjem et al., 2010, 2011). For the EU, the recommended range is USD 1.75-
5.25 million (2005), with a mean of 3.5 USD million. For the US, the review made by 
Robinson and Hammitt (2015) provides a range for  VSL between 1 to 10 million USD 
with a central estimate of USD 7.5 million. For Canada, the recommended value is around 
CAD 5.0 million with a range of 3.4 to 6.3 CAD million (Chestnut and De Civita, 2009), 
and for Australia the VSL is set around AUD 3.5 million. The UK department of transport, 
which has made calculations since 1993, recommends 1,080,760 GBP as a midpoint of a 
range of 750.000-1.250.000 GBP (OCDE, 2011). 
 
2.2. The value of a life year 
The value of a life year (VOLY) or Quality Adjusted Life Year (QALY) can be calculated 
from SP surveys as well, obtained from cost-effectiveness analyses and inferred from VSL 
estimates (Ryen and Svensson, 2015). VOLY can be calculated from VSL estimates 
assuming a mean value for life expectancy and a discount rate (Abelson, 2003). For 
instance, a VSL of 1,000,000 GBP, considering a discount rate of 5% and 40 years of life, 
would lead to a VOLY of GBP 55,068 (assuming perfect health status, as done by Abelson, 
2003). The main difference between QALY and VOLY is that the latter does not 
necessarily take into account the quality of a life year gained.  
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In contrast to the vast literature on VSL, there have been relatively few studies on VOLY. 
Nevertheless, Desaigues et al (2011) argue that VOLY might be a more realistic value than 
VSL because air pollution - the usual case for SP studies on VSL - cannot be considered 
as the primary cause of individual death but a factor shortening life. In terms of policy 
applications, the UK is one of the few countries that uses VOLY, using a value of GBP 
29,000 for the VOLY in normal health (Chilton et al., 2002). The European Commission 
recommends a range for VOLY of €50.000-100.000 (European Commission 2009, 
Annexes p 43), while Ryen and Svensson (2015) made an extensive review of the QALY 




3.1. Survey development and administration 
The three ways to communicate an identical health benefit that we considered were: a 
reduced risk of suffering a fatal cardiovascular incident (Outcome Frame A), an exactly 
equivalent extension in months of life expectancy (Outcome Frame B) and an exactly 
equivalent increase in the probability of reaching the individual’s full lifespan (Outcome 
Frame C).  
Nielsen et al. (2010) and Hammitt and Tunçel (2015) have shown that respondents have 
preferences in valuation of mortality risk reduction between different timing profiles or 
risk reductions which all provide identical life expectancy gains.  Unlike Nielsen et al. 
(2010), we study alternative risk communication or risk framing methods for presenting 
the same risk reduction, rather than alternative and different temporal profiles of risk 
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reductions. Figure 1 shows a flow chart of our survey design and questionnaire versions. 
Ethical approval for this study was obtained from the Ethical Research Committee of the 
School of Biological Sciences, Queen’s University Belfast. 
 
Figure 1 about here 
Table 1 describes the number of questions and the type of questions for every part of the 
survey. The questionnaire had 70 questions divided into eight sections: health, physical 
activity, diet, choice, follow-up, locus of control and sociodemographic characteristics. We 
began with 19 general questions about health adapted from the MOS SF36 health 
questionnaire (Mc Horney et al 1994). The subject’s personal data was then incorporated 
in the QRISK1 prediction algorithm (Hippisley-Cox et al., 2007) to estimate the 
respondent’s own CVD mortality risk over the next 10 years (see Grisolía et al 2013; 
Grisolía et al 2015 and Boeri et al 2013). We included a personal physical activity 
questionnaire of five questions based on the UK National Health Service version of the 
International Physical Activity Questionnaire (IPAQ) (Craig et al, 2003) to elicit the 
respondent’s engagement with moderate physical activities (household work, gardening, 
shopping), moderate exercise (walking, cycling) and vigorous physical activities. 
Table 1 about here 
 
Having initially determined the health status quo and physical activity habits of the 
respondent, the questionnaire also explored a respondent’s eating habits to later design the 
individually tailored SP exercise. As we deemed it impractical for a CAPI interview to use 
a diary of food intake during one week (Alliance, I. U. N., 2001), we focused on eliciting 
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the respondent’s consumption of food items with a high fat content, as these items could 
lead to high levels of blood cholesterol and, therefore, are likely to contribute to CVD. We 
adapted to the Irish diet the Block Questionnaire (Block, 2000). This is a tool developed in 
the nutritional literature that offers a snapshot of an individual’s level of fat intake through 
questions about the eating frequency and the portion size for 19 selected items (Joyce et al, 
2007). Respondents were asked the frequency of consumption of these items from ‘never’ 
to ‘five or more times a week.’ Each item was presented on a separate screen. After the 
frequency, individuals were asked about portion sizes and cooking styles. We would later 
use the answer to the Block Questionnaire to build the ‘diet’ attribute for the choice 
experiments (CE) questions, as described below.  
From this point, the questionnaire was split into two parts: the risk questionnaire and the 
lifespan questionnaire (Outcome Frames A and C) contained a tutorial about probability. 
This risk tutorial explains the idea of probability using visual aids (Alberini et al., 2004). 
For Outcome Frame B (Life Expectancy Gains) although the tutorial on probability was 
not necessary, as this version did not engage the respondent with a probability exercise, a 
section of equivalent length was included on individual life expectancy tables. Each 
experiment continues with 10 CE questions, followed by three questions about whether the 
subject had paid attention to the attributes in the experiment. Finally, there were 13 socio-
economic questions. 
To finalize the survey questions and improve its wording, we completed five focus group 
with 12 participants in each group recruited through community centres in Northern Ireland. 
Each participant was paid 25 GBP for their participation. Three focus groups took place in 
Belfast - two in Queen’s University Belfast premises and one in a community centre ina  
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deprived area of the city. One focus group took place in Holywood, a wealthy town, and 
another focus group was organized in Derry/Londonderry, where participants came from 
lower socio-economic groups. Participants were at least 40 years old with a roughly equal 
split between female and male in each focus group. The focus group template contained 10 
questions including rating factors affecting food choices, relationship between lifestyles 
and health risks and a rating exercise about factors preventing risks of a heart attack. During 
the session we tested the tutorial on probability and risk and asked a contingent valuation 
question on the WTP to reduce the risk of a heart attack. This latter question was used to 
provide priors for our CE pilots. The sessions also revealed that most people are aware of 
the connection between lifestyle and CVD risks.  
After completing the focus groups, the survey was administered by a marketing research 
firm in Northern Ireland to 1,008 randomly selected individuals interviewed in their 
homes from February 2010 to July 2011. We selected representative segments of 
different socioeconomic groups using multi-stage random sampling. To maximize 
response rate, the survey company we hired for the data collection aimed to achieve a 
70% response rate requiring interviewers to make at least 5 calls to each address at 
varying times of the day and evening, with at least one call back been made at the 
weekend before an address was recorded as a non-contact. 
 
 




Individual’s current CVD mortality risk was given as the status quo and health benefits 
were presented in terms of mortality risk reduction expressed in percentages. Although 
health risk is a negative concept, the outcome was positively framed – as a reduction of an 
individual’s  CVD mortality risk in the next 10 years. An example of an Outcome Frame 
A choice card is shown in Figure 2. 
 
Figure 2: Example of a Outcome Frame A choice card 
About here  
 
 
3.3.  Outcome Frame B: Increase in Life Expectancy Framing  
 
In Outcome Frame B, the individual was informed about their likely life expectancy 
considering their age and gender. This information was obtained from the Interim Life 
Table published by the Government Actuary’s Department in the United Kingdom. A 
respondent’s “status quo” health was presented in terms of this life expectancy. Should the 
subject modify their diet and exercise habits, there would be an identical benefit in 
mortality risk reduction to that in Outcome Frame A but this was converted into increased 
months of life expectancy.  
The Interim Life Table uses the following parameters to calculate  life expectancy: 
- x denotes year 
-  qx is the mortality rate between age x and x+1 
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- lx indicates the number of survivors of age x over a cohort of 100,000 births  
- dx is the number of individuals dying between year x and x+1. This can be obtained 
with the product of survivals and mortality rate; that is dx= qx*lx 
- mx central mortality rate. For a particular cohort of year x, the mortality rate for a 
period of three years (considering the average population of this subgroup over the 
defined period) 





- Tx is the sum of Lx for age x to the oldest age, it will gives the number of years lived 
from age c 
- ex represents life expectancy at age x which is obtained as the ratio Tx/Lx 
For each cohort and gender, the Interim Life Table provides an average mortality rate qx. 
This ratio would be increased by the CVD mortality risk that was estimated for each 
individual, altering their life expectancy to eqx (denoting q the individual). This was the 
status quo condition. As our experiment offered a reduction in individual’s CVD risk, for 
every alternative, dqx is recalculated according to the experimental design. Altering dqx 
brings a longer expectancy and it is possible to estimate the difference from the initial eqx. 
These differences were transformed into months. Using a purpose specific Visual Basic 
program, the life expectancy for each respondent was calculated ad hoc during the 
interview using the respondent’s data. Table 2 provides an example of the health benefits 
part in an Outcome Frame B choice card. Details of this algorithm are presented in the 





Table 2 about here 
 
3.4. Outcome Frame C: Increased Probability of reaching your full life span Framing 
The probability of reaching the full life span expresses the probability that the individual 
would achieve the totality of their anticipated life expectancy at birth. This information 
was retrieved from the survivorship rate lx in the Interim Life Table. This parameter 
represents the proportion of individuals of a particular age cohort that survive to a certain 
age. This was used as the baseline for the probability of reaching an individual’s life span. 
Increases in this probability which were exactly equivalent to the reduction of CVD 
mortality risk in Outcome Frame A were estimated ad hoc in the same manner as we did 
in Outcome Frame B. Since increases were small, they were shown in figures per thousand, 
as well as in percentage terms (see Table 3). Before displaying the choice scenarios, 
respondents were trained about the concept of life span and survival rates. Figure 3, taken 
from Nielsen et al (2010), shows a visual aid used for this purpose.  
 
Figure 3: Survival Rates by Age Cohort: Taken from Nielsen et al (2010) 
About here 
 






Table 4 reports the current initial mortality risk of 5% for a 50 years old male respondent, 
calculated with the QRISK1 algorithm (Hippisley-Cox, 2007), and the alternative 
hypothetical reduced risks for Choice A and Choice B  in the 10 Choice Occasions 
presented to this respondent by our experimental design. The table then presents the 
corresponding current life expectancy gains and the current and improved probabilities for 
reaching the full life span. 
Table 4 about here 
3.5. Experimental design 
Our choice experiments questions entailed four attributes: diet, physical activity, CVD 
mortality risk – as defined by Outcome Frames A, B or C – and a cost to the respondent. 
Physical activity was defined as minutes spent in moderate forms of physical exercise per 
day. The levels of this attribute were: the current level of physical activity, and increases 
by 10, 20, 30, or 40 minutes per day compared to the current level. The CVD mortality risk 
was defined as the probability of a fatal heart attack in the next ten years. The level for the 
current life style was the one resulting from the QRISK1 prediction algorithm. The levels 
for the alternative scenarios were calculated as a reduction in such a risk by 40%, 50%, 
60%, 75% and 85%. Therefore, for a respondent whose current risk was equal to 5%, a 50% 
reduction would result in a risk of 2.5%. Reductions in risk were transformed for Outcome 
Frames B and C using the procedure described above. We were therefore able to 
communicate identical CVD mortality risk reductions using three different Frames or 
methods of risk communication. The cost for achieving these benefits was described as an 
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increase in the money spent on food and physical exercise per week. Levels were 0, 2, 5, 
7, 10, 15 and 18 GBP. The diet attribute was built from the adapted Block Questionnaire 
where we selected, for each respondent, the five (unhealthy) food items most frequently 
consumed by that individual. This information was presented to respondents as their 
current choice. The alternative hypothetical scenarios were described in terms of reductions 
in the consumption of these five items and an increase in fruit and vegetables. We selected 
four levels for the diet attribute defined in terms of overall fat content. Considering the 
current diet as the reference value, we defined “light”, “medium”, “high” and “restricted” 
diets, corresponding to reductions in fat intake by 10% (light), between 20% and 30% 
(medium), between 40% and 50% (high) and between 60% and 75% (restricted) from the 
current diet respectively. This approach allowed us to compare diets across respondents 
and build a variable expressed in terms of reduction of grams of fat from the current diet. 
Table 5 shows the attributes and their levels used in this CE. 
 
Table 5 about here 
 
Once the attributes and levels were decided, we inserted 10 choice sets, with each choice 
set described by three options, a respondent’s current lifestyle and two hypothetical 
lifestyle alternatives. To determine the choice sets and the combination of attribute levels 
for each alternative, we used a Bayesian D-efficient experimental design (Bliemer et al., 
2009; Scarpa, Campbell and Hutchinson, 2007; Ferrini & Scarpa, 2007). This design 
consists of a combination of attributes and levels that maximizes the information obtained 
from respondents. In practical terms, this means a design that yields the smallest standard 
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error (Rose et al., 2008). For the initial experimental design, we set our priors to zero 
(Kessels et al 2006). In the following designs, we inserted as priors the estimates from a 
multinomial logit model obtained using the data from the pilot surveys. All designs were 
implemented in VBA in Excel following the recommendations by Rose et al (2008).  
Every survey was pre-tested twice – except Outcome Frame C, which was tested only once 
due to budget constrains – with pilot questionnaires administered to a sample of 90 
individuals. This helped us improving wording, show cards photos, position of questions, 
and rephrasing to simplify the questionnaire.  
 
Table 6 about here 
4. Econometric Models  
Choice Experiments are based on the Random Utility Theory (Train, 2011) which 
considers that an individual’s choices produce certain utility U which contains a part V that 
can be measured in terms of the attributes of each alternative (Lancaster, 1966), and another 
part  that cannot be observed and therefore  is considered a random term. When facing a 
set of J alternatives, individuals will select the one providing the highest utility. As shown 
in (1), the utility associated with option j can be decomposed into V, the modelled 
component and , the error component. The first term can be expressed as the sum of the 
product of k attributes x multiplied by their weights βk. 
 




A Random Parameter Logit (RPL) model allows for differences in tastes by assuming that 
β are not fixed but vary across respondents (Train, 1998). We apply a classical estimation 
with 1,000 draws and assuming a Normal distribution for random parameters in the RPL. 
Correlation amongst attributes was assumed absent and therefore the covariance matrix for 
the RPL model estimation was diagonal. In addition, we estimated a Willingness to Pay 
Space (WTP) model (Train and Weeks, 2005). To test hypothesis H1 and H2 we compare 
the WTP estimates from Outcome Frames A, B and C for the CVD risk reduction attribute, 
everything else being equal.  We run two models for each Outcome Frame: a Random 
parameter logit (RPL) model, displayed in Table 7 and a Willingness To Pay Space (WTP) 
model shown in Table 8. All models were estimated using Biogeme (Bierlaire, 2003). From 
the WTP for reducing by 1% fatal CVD risk we obtained the VSL converting this payment 
in a 10-year weekly payment and dividing it by 1%, considering the actual average risk in 
the sample. To calculate the VOLY from Outcome Frame B, we took the WTP for a one-
month life extension and multiplied it by the number of weeks in one year, 52, and further 
multiplied it by 10 for a 10-year life expectancy gain.  
The econometric models use the independent variables Fat, Exercise, Cost, Risk, LE (Life 
Expectancy) and Lifespan. Fat represents the sacrifice of a respondent’s current diet in 
terms of grams of fat per week that the individual is asked to give up in the hypothetical 
scenarios. This variable was created using the information from the adapted Block 
Questionnaire and translated into grams of fat using the study of calories and fat provided 
by McCance and Widdowson (2002).  Exercise represents the contribution to utility of one 
additional minute of moderate exercise.  Cost is the payment for changes in lifestyle, 
justified in terms of increasing costs of healthy diets and exercise, measured in GBP per 
19 
 
week. Risk is the risk of suffering a fatal CVD event over the next ten years, expressed on 
a percentage basis. LE represents extra months of life, Lifespan represents the increasing 




Table 7 about here 
5.1. Random Parameter Logit 
Before running our econometric models, we compared the three subsamples using the 
Kruskal-Wallis test for selected socio-demographic variables. Table 6 displays these 
results. We cannot reject the null hypotheses of no differences across the three Outcome 
Frames samples at the 5% significance level for all variables except for unemployed and 
degree holder. The sample that received Outcome Frame A comprises more unemployed 
respondents than the other two samples, whilst the group that received Outcome Frame B 
includes less highly educated respondents. 
 
 In the econometric models, we allowed all parameters to be random, including the 
alternative specific constant (ASC), except fat, since its spread (σ) was not statistically 
significant. Outcome Frame B, which presented the health outcome as life expectancy 
gains presents the highest log-likelihood (or lowest in absolute terms), and best AIC and 
BIC statistics, thus clearly outperforming the models for Outcome Frames A and C. The 
key attribute of interest in each model is the one that captures the CVD mortality risk 
reduction benefits. Surprisingly, Outcome Frame C reports a negative and statistically 
significant coefficient for the increase in probability of achieving a person’s full life span, 
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suggesting that people prefer a scenario with a lower probability of achieving their full life 
span.   
To further explore the importance of CVD risk in people’s choices, we look at the spread 
of the coefficient estimates σ for this attribute in the three models. Whilst we notice that 
Outcome Frames A and C have large relative values for σ compared to the size of the mean 
µ, Outcome Frame B has a relatively small value for σ, indicating that Outcome Frame B 
elicits more homogeneous preferences. Since the model employs a normal distribution for 
the spread of CVD risk, we can estimate the percentage of people exhibiting positive or 
negative preferences towards CVD risk reduction. For Outcome Frame B, about 93% of 
individuals exhibit positive preferences for CVD risk reduction, for Outcome Frame A. 
this percentage falls to about 70%, and for Outcome C it further drops to 39%. These results 
would indicate that gains in life expectancy are a better way to present a CVD health 
dividend to a large representative sample of the public.  
The sign on the “status quo” parameter indicates whether individuals are satisfied with 
their current situation. All models show that the coefficients for the status quo are 
negative and significant, suggesting that individuals are discontent with the current 
situation. Interaction terms between socio-economic variables and the status quo are not 
statistically significant in Model A. In model B, highly educated people (degree holders) 
are less likely to choose the current situation, whilst respondents enjoying good health 
and male respondents are more likely to choose their current lifestyle.  The interpretation 
of the results for model C is more problematic, as we find a counterintuitive sign for the 
interaction term between good health and the current situation.  
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It is interesting to analyse how these models affect stated behavioural change suggested 
in the experiment. Individuals seem content with the idea of dietary change in all models, 
except model C. As for exercise, the perception is positive particularly in Outcome Frame 
B, where about 90% of individuals see more exercise as something positive compared 
with 60% for Outcome Frame A. Summing up, in terms of desirable CVD relevant 
behavioural change forecasts, the most “persuasive” model seems to be Outcome Frame 
B. 
 
5.2. Willingness-To-Pay Space models 
 
Willingness-to-pay estimations were made using WTP space models, reported in Table 
8. In terms of goodness of fit, the best WTP space model is B, with the lowest log-
likelihood in absolute terms, and better AIC and BIC statistics. The coefficients for Fat 
and exercise are scaled and must be divided by 100 when interpreting their meaning. In 
addition, minutes of exercise were transformed into Metabolic Equivalent Task (MET), 
a measure for units of energy (see for instance Jette et al, 1990; Ainsworth et al., 1993). 
The results from Outcome Frame B show that about half of the respondents are willing 
to pay to increase their physical activity, with quite some variation in the sample, as 
captured by the standard deviation. Under Outcome Frame A, since mean WTP is 
negative, we see that most individuals should be compensated to increase their physical 
activity. In contrast, with Outcome Frame C, individuals show on average a positive WTP 
to increase their physical activity levels.  
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The mean WTP coefficient estimates for reducing fat from the diet are negative for all 
Outcome Frames, showing that, on average, people need to be compensated to reduce fat 
intake from their diets. Around 70.5% of the range of WTP is negative in Outcome Frame 
A, 80% in Outcome Frame B, and 100% in C. Thus, individuals seem to be less reluctant 
to follow a diet when they are being offered a longer life as a reward than a 
straightforward risk reduction or higher probability of achieving a full life span. Not 
surprisingly, exercise is still the most preferred intervention (Ryan et al 2015) for which 
respondents would require lower payments on average than for dieting.  
Finally, the mean WTP for CVD risk reduction shows that people need to be 
compensated by about £1/week to have their fatal risk increased by 1% as shown by 
Outcome Frame A. Outcome Frame B shows that respondents are willing to pay about 
£10/week to extend their life expectancy by 1 month. Outcome Frame C reports a 
negative mean WTP for increasing the chance of achieving the full life span. When we 
look at the distribution of WTP for CVD risk reduction, we find that, under Outcome 
Frame A and B, about 93% and 85% of the sample respectively have a positive WTP for 
reducing their CVD risk, whilst with Outcome Frame C about only 44% have a positive 
WTP for increasing their probability of achieving their full life span. This latter result 
highlights that the majority of respondents presented with Outcome Frame C have a 
negative WTP for CVD risk reduction, a counterintuitive result. 
When we further analysed the results excluding non-traders (respondents who always 
select the same alternative) or non-demanders (people who always choose their status 






From Outcome Frame A, for a 1% reduction in the risk of death from CVD (over the next 
ten years), we obtain a WTP of 511.68 GBP, which leads to a VSL estimate of 814,777 
GBP. Using the WTP obtained from the Life Expectancy Model (Outcome Frame B) we 
estimate the VOLY as 63,024 GBP. The VSL from Outcome Frame A obtained here is 
24% smaller than the central value recommended by the UK Department of Transport, 
although it is within the recommended range. Conversely, the VOLY (Outcome Frame B) 
calculated here is above the value applied in the UK but it is within the range 
recommended by the European Commission. It is interesting to observe that our VOLY 
of 63,024 GBP is almost exactly the same as that recommended by Ryen and Svensson 
(2015). Indeed, their estimate was €74,159 and the appropriate conversion into euros, for 
our estimate is €73,738 (using 2010 annual exchange rate). From the VSL obtained in 
Outcome Frame A we can infer, assuming 40 years of remaining life and a discount rate 
of 3%, a VOLY of 34,222 GBP. Similarly, using the VOLY from project B, and applying 
the same discount rate of 3%, we estimate a VSL equal to 1,500,488 GBP.  
Model B, based on life expectancy, is not only able to generate a VOLY that accords 
with the current literature and provides the best goodness of fit; it also offers additional 
insights from the socioeconomic interactions. The enhanced life expectancy scenario, 
without the need to instruct respondents on the concept of probability, and by providing 
a positive health frame, has proved most effective in guiding respondents into choosing 
healthier lifestyles. Outcome Frame A generates reasonable results in behavioural terms 
that mirror Outcome Frame B, though, in the case of this exercise, Outcome Frame B 
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shows a higher commitment from individuals since the positive range is larger. In terms 
of monetary values, its WTP for CVD risk reduction is greater than B.  
The results obtained from Outcome Frame C show that the majority of respondents need 
to be compensated to choose a scenario with an increased probability of achieving their 
full life span. Whilst about 44% of the sample administered with Outcome Frame C has 
a positive WTP for CVD risk reduction, about 56% need to be compensated. Therefore, 
we do not recommend using these results for estimating VSL or VOLY. The results from 
Outcome Frame C also shows very high levels in terms of WTP for increasing physical 
activity levels and willingness to accept for reducing fat intake. To investigate these 
abnormal results, we carried out some one-on-one interviews to explore any weaknesses 
with Outcome Frame C. The feedback we obtained from these interviews are that people 
require much more training to properly understand the scenario of the probability of 
achieving the full life span. Under Outcome Frame C, people are told that, given their 
age, health and lifestyle, they have a certain (fairly high) probability of achieving their 
full life span. People are then told what this age is. They are then presented with 
hypothetical scenarios where the probability of achieving their full lifespan is increased 
(by very small amounts) This frame is rather different from Outcome Frame A or B, 
where the hypothetical scenarios are presented as either a mortality risk reduction (and 
therefore one can expect to live longer as a consequence of a reduction in  mortality risk), 
or an increase in the number of years of life. Outcome Frame C does not present such an 
intuitive increase in life expectancy. Respondents are not told that they will live longer 
than a certain age, but that they will be more likely to achieve the age of their full life 
span. To improve the understanding of Outcome Frame C, the questionnaire would have 
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to become much longer to accommodate for an improved training in the concept of 
survivorship and the probability of achieving the full life span. Such a modified 
questionnaire, necessarily, would not be comparable with the questionnaires for Outcome 
Frame A and B, making it impossible to compare the different Frames as this would 
introduce a questionnaire length bias. Many of the problems of using a survivorship 
approach to communicating a specific (in our case CVD) risk reduction can be 
appreciated by inspecting the exactly equivalent choices in the choice sets outlined in 
Table 4. In Frame A we can see that some of the Option A and Option B choices can 
substantially reduce the specific CVD mortality risk (from 5% to 2% over a 10 years 
period). By contrast Frame C looks at the effect of CVD risk reduction in the context of 
survivorship and reaching your fully lifespan. This places CVD risk reduction in the 
context of all mortality risk reduction where the percentage increases in reaching your 
full lifespan (from reduced CVD risk) in Table 4 look very small, mostly increases from 
67% to 68.5% or less. Other papers which have used this survivorship approach such as 
Nielsen et al (2010) have used extensive experimental laboratory training of subjects but 
have still faced this problem. In investigating preference between different ways of 
generating a 6 month gain in life expectancy Nielsen et al (2010) state “the reason why 
a six- month gain was chosen is because compared with the risk reductions (and implied 
life expectancy gains) in a typical VSL survey, even a six month gain in life expectancy 
is a substantial good ( for someone of average age the risk reduction in a typical VSL 
survey would generate a gain in life expectancy of a few hours or at most days and 
certainly less than a month)”  In terms of our study CVD risk reduction is clearly a very 
substantial good with Table 4 showing Life expectancy gains of up to 13 months. Even 
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in the case of a 13-month life expectancy gain the equivalent probability of reaching your 
full life span only increases from 67% to 68.5%. Another paper by Mahmud (2009) on 
valuing mortality risk reduction in developing countries shows that using a survivorship 
approach even when given prior information on age related objective mortality risk 
people on average subjectively underestimated their own survivorship at younger and 
overestimated it at older age cohorts.     We conclude, therefore, that further research 
should be done to investigate the use of Outcome Frame C for policy making before 
arguing that this frame is suitable for research purposes in the field. By contrast, increased 
life expectancy in Frame B has worked well in our case because CVD mortality risk is 
higher than many other specific mortality risks investigated in this type of study and this 
transfers to substantial increased in life expectancy that respondents find easy to value.  
 
7. Conclusions 
This paper investigates how individuals state they would change their lifestyles in 
exchange for certain health benefits. Identical benefits were expressed as a reduction of 
fatal CVD mortality risk in the next 10 years (Outcome Frame A), as a corresponding 
life expectancy gain in months (Outcome Frame B) and as an increase in the probabilities 
of reaching the individual’s estimated full life span (Outcome Frame C). Using our 
Outcome Frame A sample, we calculated the value of statistical life in the context of 
CVD mortality risk as 814,777 GBP. From the Outcome Frame B life expectancy frame, 
we estimate the value of one extra life year (VOLY) as 63,024 GBP.  
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In terms of our models’ goodness of fit and the significance of the relevant parameters,  
Outcome Frame B, that presents CVD risk reduction in the form of life expectancy gain, 
appears to be the most persuasive in achieving stated behaviour change intentions.  
We also find that Outcome Frame B provides a higher mean WTP for CVD risk 
reduction, compared to the mean WTP estimated from Outcome Frame A and B. These 
results confirm that we cannot reject our hypotheses H1 and H2: (1) a gain-frame 
presentation of health benefits is more valuable than a gain-frame presentation of reduced 
health risks; and (2) presenting CVD risk reduction in terms of additional life years leads 
to higher WTP values. This might be the consequence of having a positively framed 
outcome and a simple message which does not require risk literacy or an understanding 
of probability. The life expectancy gain approach (of Frame B) is also particularly 
suitable for this specific study because CVD mortality risk is much greater than many of 
the mortality risks in VSL studies (such as from air quality and transport safety). As a 
result, life expectancy gains of up to and over 12 months can result from CVD risk 
reduction.  By contrast, the probability of reaching a full life span (Frame C) is the least 
persuasive, and we find that our sample may have had difficulties in grasping the 
meaning of this novel method of benefit framing.  
 
Our results are consistent with the literature; in the sense that gain-framed messages are 
persuasive for behavioural change intentions. We also find that when a gain-framed 
message is described in terms of health benefits, people are more likely to state that they 
wish to engage with healthier lifestyles.  Personal lifestyle change necessitates individual 
agency and self-efficacy and this seems to be the reason behind the success of gain framing 
(Gallagher and Updegraff, 2012). It seems that in our case the combination of gain framing 
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and an outcome expressed in terms of health benefit intensifies the effectiveness of the 
message.  
This work has some limitations. All SP studies might be affected by hypothetical bias. In 
our case the real behaviour would imply a profound modification of people’s lifestyles over 
years which requires a long commitment. On the other hand, the sample might be 
representative solely of the Northern Ireland population and these results cannot be 
extrapolated beyond that region. Finally, although the health benefits were originally 
equivalent by design, there are slight differences in the questionnaire administration that 
might have affect the results. It is disappointing that the results from Outcome Frame C, in 
which we presented the probability of achieving the full lifespan, were inconclusive and 





More specifically the method follows these steps: 
1) With the risk calculated per respondent we modify qx to qx’ which is higher  
2) Recalculation lx considering the new qx’ 
3) A new estimation of the new dx’ with the new qx’ 
4) Calculation of Lx’ 
5) From the age x sum of Lx will provide the total number of years lived (Tx’) from 
age x. 
6) The new life expectancy ex is calculated in each individual case.  
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This is done, for every individual once to set the baseline of life expectancy based on 
his/her risk and, for every alternative in every choice set. Since there is always a reduction 
of risk, this reduction will imply an increase in life expectancy. The difference, in months 
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Figure 1: Flowchart of the survey design and questionnaire versions for Outcome Frames 
A, B and C 
General questions 
about health (F12) 
Questions about diet 
Tutorial about 
probabilities 
CVD tool. The person 
is informed about 
his/her real CVD risk 
risk 
Project B. 
Benefits are given as 
Life Expectancy gains in 
months. N= 336 
Project A. 
Benefits are given as a 
reduction of fatal CVD 
risk in the next ten 
years. N= 336 
 
Project C. 
Benefits are given as 
increases in the 
probabilities of 
reaching expected life 
span. N= 336 
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Type of question 
General questions about health  19 adapted from the MOS SF36 health 
questionnaire (Mc Horney et al 1994) 
Questions about physical activity 5  
Questions about diet 19 Adaptation of Block questionnaire 
Tutorial about probabilities 
CVD tool. The person is informed about his/her real CVD risk 
Choice scenarios 10  Outcome Frame A: fatal CVD risk 
in the next ten years. 
 Outcome Frame B. Life 
Expectancy gains in months 
 Outcome Frame C. probabilities 
of reaching expected life 
Follow up questions 2  
Locus control attitudinal questions  5  










Figure 3: Survival Rates by Age Cohort: Taken from Nielsen et al (2010) 
 
 
Table 2: How the health benefit part was expressed in Outcome Frame B 
 Current choice Option A Option B 
Extra months of 
life expectancy 
0 40 30 
 
 
Table 3: How the health benefit part was expressed in Outcome Frame C 
 Current choice Option A Option B 
Increase in the 
probability of 
reaching your 
full life span 
0 5 in 1,000 
(0.5%) 






Table 4 Exactly equivalent health gains for choice sets in Outcome Frames A, B and C 
 
  Outcome Frame A:  
Mortality risk reduction 
(%) 
 Outcome Frame  B:  
Life expectancy gain 
(months)  
 Outcome Frame C:  
Probability  of  reaching 
your full life span (%) 
choice set current A B current A B current A B 
1 5 0.75 1.25 0 12 10 66.5 68.2 67.0 
2 5 0.75 0.5 0 12 13 66.5 67.6 67.7 
3 5 2.5 1.25 0 7 10 66.5 67.0 67.4 
4 5 1.25 0.75 0 10 12 66.5 67.0 67.7 
5 5 0.5 3 0 13 5 66.5 67.6 67.0 
6 5 1.5 1.25 0 10 10 66.5 67.9 68.2 
7 5 0.75 0.75 0 12 12 66.5 67.2 67.4 
8 5 0.75 2 0 12 8 66.5 68.9 67.4 
9 5 3 2 0 5 8 66.5 67.4 68.2 
10 5 1.25 0.75 0 10 12 66.5 68.2 68.6 
 
 
Table 5: Attributes and levels 
 Attribute Levels 










Diet (reduction of the 
consumption of the 
respondent’s five most 
unhealthy food items) 
Current, light, medium, high and restricted diet 
Cost (GBP per week) 0, 2, 5, 7, 10, 15, 18 
Physical Exercise 
(increase in daily 
minutes) 
0, 10, 20, 30, 40 
Specific  gains in 
terms of health 





























Table 6: Descriptive statistics on the samples 
 Samples Total samples Census 
 A B C Total (n) Total (%) (%) 
Employment status 
Employee 196 202 195 593 58.52 57.75 
 χ2 = 0.3519; df = 2; p = 0.8387 
Unemployed 41 10 22 73 7,2 3.55 
χ2 = 23.4036; df = 2; p = 0.0001 
Students 2 4 2 8 0,8 0.24 
χ2 = 1.0070; df = 2; p = 0.6044 
Retired 61 63 76 200 19,8 9.77 
χ2 = 2.4801; df = 2; p = 0.2894 
Looking after home/family 20 10 23 53 5,3 8.63 
χ2 = 5.5309; df = 2; p = 0.0629 
Gender 
Men 147 148 163 458 45,8 48.19 
χ2 = 1.9269; df = 2; p = 0.3816 
Education 
Degree holder 83 59 93 235 23.3 25 
χ2 = 10.1556; df = 2; p = 0.0062 
 Age (averages) 
Age 50,85 52,24 52,24 51.77  51,31 
χ2 = 5.2964; df = 2; p = 0.0708 
The χ2 test reported shows the result of the Kruskal-Wallis test for the null hypothesis of no difference across the 








Table 7: RPL 
  Outcome Frame A – 
Risk 
Model A  
Outcome Frame B - Life 
Expectancy 
Model B 
Outcome Frame C – Life 
span  
Model C 
 Value  St. Err. Value  St. Err. Value  St. Err. 
status quo μ -2.89*** 0.578 -7.56*** 1.15 -4.49*** 1.28 
 σ -4.23*** 0.397 20.2*** 2.73 5.52*** 1.24 
status quo * education (degree holders)  0.212 0.708 -8.44*** 1.36 -0.371 3.57 
status quo * good health (stated)  0.352 0.601 6.91*** 1.01 -2.82** 1.21 
status quo * male  0.254 0.560 8.50*** 1.33 -1.02 1.31 
Cost (GBP) μ -0.222*** 0.0211 -0.160*** 0.0226 -0.00796*** 0.0113 
σ 0.199*** 0.0173 0.169*** 0.0263 0.00244*** 0.0211 
physical activity 
(additional minutes of moderate intensity 
exercise) 
µ 0.0263*** 0.00955 0.0331*** 0.00974 0.0239*** 0.591 
σ 
0.113*** 0.0130 0.0248*** 0.0154 
0.00285 0.00469 
Diet (giving up 1 gram of fat) µ 0.0965*** 0.265 0.00230*** 0.000971 -0.00971*** 0.200 
Risk of suffering CVD disease 
(%) 
µ -0.182*** 0.0645     
σ 0.350*** 0.0631     
Life Expectancy 
(extra months of life) 
µ   1.25*** 0.162   
σ   0.865*** 0.109   
Life span 
(Increase in probability of reaching your life 
span) 
µ     -0.140* 0.136 
σ   
  
0.488*** 0.0605 
Log likelihood -2397.623 -1560.216 -2197.277 
Sample size n 3360 3360 3360 
Individuals 336 336 336 
ρ2 0.350 0.574 0.401 
Number of parameters k 12 12 12 
Akaike Information Criterion (AIC) 4,813.246 3,138.432 4,412.554 
Bayesian Information Criterion (BIC) 4,868.323 3,193.509 4,467.631 
*** P value < 0.001  
** P value < 0.01 




Table 8: WTP SPACE MODELS 
  Outcome Frame A – 
Risk 
Model A  
Outcome Frame B - 
Life Expectancy 
Model B 




 Value  St. 
Err. 
Value  St. Err. Value  St. Err. 
status quo  -2.10*** 0.148 -0.646 0.826 -1.25*** 0.219 
Cost (GBP) μ -0.325*** 0.0274 -0.188*** 0.0305 -0.0205*** 0.00825 
σ -0.355*** 0.0280 0.159*** 0.0262 0.00574 0.00376 
physical activity 
(Additional minutes of moderate intensity 
exercise) 
µw -0.822*** 0.129 9.32 9.60 79.4*** 38.9 
σw 
1.95*** 0.198 44.1*** 12.4 83.3 79.4 
Diet 
(giving up 1 gram of fat) 
µw -4.69*** 0.557 -1.26* 0.724 -18.9** 11.6 
σw 8.67*** 0.921 1.52*** 0.715 0.797 0.985 
Risk of suffering CVD disease 
(%) 
µw -0.984*** 0.145     
σw 0.656*** 0.0812     
Life Expectancy 
(extra months of life) 
µw   10.1*** 2.03   
σw   9.67*** 1.86   
Life span (Increase in probability of reaching 
your life span) 
µw     -0.655* 0.451 
σw     4.39* 3.29 
Log likelihood  -2,521.571 -1604.506 -3569.886 
Simple size n  3,360 3360 3360 
Individuals  336 336 336 
ρ2  0.314 0.563 0.033 
Number of parameters k  9 9 9 
Akaike Information Criterion (AIC)  5,061.142 3,227.012 7,157.772 
Bayesian Information Criterion (BIC)  5,116.219 3,282.089 7,212.849 
 
*** P value < 0.001  
** P value < 0.01 
* P value < 0.1 
 
 
